Abeona Therapeutics (ABEO) Assets (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Assets of $198.5 million for Q1 2026, up 99.76% year-over-year from $99.4 million in Q1 2025, and down 9.6% quarter-over-quarter from $219.6 million in Q4 2025.
Abeona Therapeutics (ABEO) Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $198.5 million for Q1 2026.
- In Q1 2026, Assets rose 99.76% year-over-year to $198.5 million; the TTM figure through Mar 2026 stood at $198.5 million (up 99.76% YoY), while the FY2025 annual figure was $219.6 million, up 101.57% from the prior year.
- Assets for Q1 2026 stood at $198.5 million, down from $219.6 million in the prior quarter.
- The five-year high for Assets was $246.2 million in Q2 2025, with the low at $38.8 million in Q3 2022.
- The 5-year median for Assets is $74.8 million (2024), against an average of $110.2 million.
- The sharpest annual moves came in 2022 and 2024: Assets sank 67.43% in 2022, then jumped 150.24% in 2024.
- Abeona Therapeutics' Assets stood at $64.2 million in 2022, then declined by 0.33% to $64.0 million in 2023, then surged by 70.2% to $108.9 million in 2024, then surged by 101.57% to $219.6 million in 2025, then decreased by 9.6% to $198.5 million in 2026.
- Business Quant data shows ABEO's Assets at $198.5 million in Q1 2026, $219.6 million in Q4 2025, and $231.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 179.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.51 Mn |
| Mar 31, 2026 | 198.49 Mn |
| Dec 31, 2025 | 219.57 Mn |
| Sep 30, 2025 | 231.10 Mn |
| Jun 30, 2025 | 246.23 Mn |
| Mar 31, 2025 | 99.36 Mn |
| Dec 31, 2024 | 108.93 Mn |
| Sep 30, 2024 | 120.59 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 74.83 Mn |
| Dec 31, 2023 | 64.00 Mn |
| Sep 30, 2023 | 66.09 Mn |
| Jun 30, 2023 | 53.55 Mn |
| Mar 31, 2023 | 53.35 Mn |
| Dec 31, 2022 | 64.21 Mn |
| Sep 30, 2022 | 38.76 Mn |
| Jun 30, 2022 | 44.72 Mn |
| Mar 31, 2022 | 55.17 Mn |
| Dec 31, 2021 | 79.59 Mn |
| Sep 30, 2021 | 119.02 Mn |